LONGEVA.

MOTS-c: adverse events and evidence limits

In Reynolds and colleagues’ study, ten healthy young men completed cycling exercise, with their endogenous MOTS-c measured in blood and muscle. They were not given MOTS-c in that study arm; peptide administration was investigated separately in mice. [1]

Exercise-associated changes in endogenous peptide levels cannot establish adverse-reaction frequencies for injected MOTS-c. The mouse experiments also do not establish clinical or long-term safety in people. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
Adverse reactions to injected MOTS-c in humansTen healthy young men — cycling exercise, endogenous MOTS-c measured; peptide administration was investigated separately in miceParticipants were not given MOTS-c in this study; exercise-associated changes in endogenous levels cannot establish reaction frequencies for injected MOTS-c, and the mouse experiments do not establish clinical safety in people[1]

References

  1. Reynolds JC, Lai RW, Woodhead JST, Joly JH, Mitchell CJ, Cameron-Smith D, Lu R, Cohen P, Graham NA, Benayoun BA, Merry TL, Lee C. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis https://doi.org/10.1038/s41467-020-20790-0.